Klin Farmakol Farm. 2005;19(2):89-94

Malaria and its treatment

Zdeněk Fendrich
Katedra farmakologie a toxikologie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova v Praze

Malaria is the most frequent imported protozoan tropical disease. Nowadays even general practitioners can more frequently come into contact with the disease when treating our tourists returning or migrants coming from endemic areas. Transmission and propagation of malaria requires a Plasmodium protozoan and a disease vector, the female Anopheles mosquito. The following four parasites are pathogenic for man: P. vivax, P. ovale, P. falciparum and P. malariae. Cyclic development of the parasite is therefore limited to two hosts, the mosquito and man. Sexual development of the parasite is located in the intestinal tract of the mosquito and asexual development, during which clinical symptoms of the acute attacks appear, occurs in human erythrocytes. The treatment of intraerythrocytic forms of the parasite, the only ones which produce clinical symptoms, is essential. According to the type of parasite several forms of malaria can be distinguished. P. vivax and P. ovale cause so called “benign“ tertian malaria recurring at approximately 48-hour intervals, i. e. each third day. P. falciparum produces malignant tertian malaria with the highest mortality rate which is responsible for several millions of victims every year and, finally, tropical quartan malaria recurring at approximately 72-hour intervals, i. e. each fourth day, which is produced by P. malariae. For treatment of the acute attacks of malaria the following drugs can be used: chloroquine and its derivatives, quinine and similar drugs such as mefloquine, certain antibiotics such as doxycycline, clindamycin and some other antimalarial drugs such as halofantrin, artesunate and atovaquon. Hepatic forms of parasite, so called hypnozoites, can be treated specifically by primaquine which is of importance in P. vivax and P. ovale but not in P. falciparum and P. malariae because they never form hypnocytes. On the other hand eradication of gametocytes by primaquine or pyrimethamine is important in P. falciparum malaria in endemic areas in order to prevent further dissemination of this dangerous disease.

Keywords: Key words: Malaria, schizontocidal (suppressive) drugs, antimalarial drugs against hypnozoites, drugs against gametocytes.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fendrich Z. Malaria and its treatment. Klin Farmakol Farm. 2005;19(2):89-94.
Download citation

References

  1. Nguwa CN (Ed). Malaria pp. 154-165 In: Therapeutic Basis of Clinical Pharmacy in the Tropics. Macmillan Publishers Ltd, London 1986.
  2. Fendrich Z. Antiprotozoární látky - malárie In: Lincová D, Fraghali H, et al: Základní a aplikovaná farmakologie. Galén a Karolinum, Praha 2002: 488-492.
  3. Scheibel LW. Antiprotozoal drugs. In: Modern Pharmacology with Clinical Applications. Craig CR and Stitzel RE (eds), 6th ed., Lippincott Williams & Wilkins, Philadelphia 2004: 606-620.
  4. Hartman J, Limbird L, Gilman A, (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th rd., New York, McGraw-Hill, 2001.
  5. Rang HP, Dale MM, Ritter JM. Pharmacology Fourth Ed., Churchill Livingstone, Edinburgh 1999: 726-734.
  6. Nohýnková E, Stejskal F. Malárie. Interní Med 2/2005.
  7. Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. Oxford University Press Inc., New York, 2002: 214-217.
  8. Mikcomedex.
  9. AISLP - aktuální verze.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.